Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
48%
OVERLAP
BY WEIGHT
9
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
33%
ALSO IN PPH
PPH
27
HOLDINGS
38%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 18.2% | 22.3% | 18.2% |
 |
NOVARTIS AG-ADR | 7.1% | 10.5% | 7.1% |
|
BRISTOL-MYERS SQUIBB CO | 4.7% | 4.3% | 4.3% |
|
ABBVIE INC | 8.2% | 4.1% | 4.1% |
|
JOHNSON & JOHNSON | 5.3% | 4.0% | 4.0% |
MEDX Overweight Relative to PPH
 |
ASTRAZENECA PLC | 5.2% |
 |
ALKERMES PLC | 4.8% |
|
IONIS PHARMACEUTICALS, INC. | 4.7% |
|
ABBVIE INC | 4.1% |
|
AMGEN INC | 3.9% |
|
ALNYLAM PHARMACEUTICALS INC | 3.7% |
|
BIOGEN IDEC INC | 3.0% |
|
CRISPR THERAPEUTICS AG | 2.9% |
|
REGENERON PHARMACEUTICALS | 2.2% |
|
BEAM THERAPEUTICS, INC. | 1.5% |
MEDX Underweight Relative to PPH
 |
NOVO-NORDISK A/S-SPONS ADR | -5.9% |
|
MERCK & CO. INC. | -5.6% |
 |
SANOFI-AVENTIS-ADR | -4.3% |
|
ELI LILLY & CO | -4.1% |
|
ASTRAZENECA PLC-SPONS ADR | -4.1% |
|
MCKESSON CORP | -3.6% |
|
NOVARTIS AG-ADR | -3.5% |
 |
TEVA PHARMACEUTICAL-SP ADR | -3.3% |
|
CENCORA INC | -3.2% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -2.7% |